The fraction dose absorbed, in humans, and high jejunal human permeability relationship. - Wikidata - wikimedia - TriplyDB

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

http://www.wikidata.org/entity/Q42131253

about

Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Quantitation of small intestinal permeability during normal human drug absorption.Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations.Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms.Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay.The Use of Rule-Based and QSPR Approaches in ADME Profiling: A Case Study on Caco-2 Permeability.Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis Predicting the extent of metabolism using in vitro permeability rate measurements and in silico permeability rate predictions.Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine.The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane.Enhancing Oral Absorption of β-Lapachone: Progress Till Date.Modern prodrug design for targeted oral drug delivery.

P2860

Q27313187-6F0D8532-E217-43DE-B7F4-D6F57911360E Q28534686-98AD9ACF-4177-42FE-A12C-1599C67C7A86 Q34273688-B6925D77-8D70-473E-88ED-399C584F9099 Q34783396-EC35FBCC-F04F-412C-9740-BCC083BA4C2A Q38874008-254A54F3-D01F-4E1A-ABF1-153252E80131 Q38922030-ADF0FC8B-A391-491A-8E34-4949BCFA756A Q39203327-C48F35E4-7DF9-430D-B2A0-464AD7BAFF2D Q39535338-89E0792E-ABB4-45A4-AEA4-44BFDE9E7286 Q41124799-0D420D1E-2948-4CA4-9D69-8B4E7C11572D Q41148725-71356CD3-9090-47D9-93A0-6843F48DF7F3 Q41986927-67C9118F-F203-48F9-8A18-9ED89205C014 Q41986961-405043FC-F91C-483C-AC8A-D87F07114E9E Q49108416-B8F0F515-F864-4BB9-8C02-8C40BD0F5C67 Q51042522-9DA0407B-1C72-4A5D-844C-3F6E92CB4B26

P2860

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

http://www.wikidata.org/entity/Q42131253

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@en

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@nl

type

label

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@en

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@nl

prefLabel

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@en

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@nl

P1433

Q42131253-EAEA311E-FE56-498F-B148-BDA297FE102A

P1476

Q42131253-0B4B98F1-585E-44B3-8247-D549ACBCC287

P2093

Q42131253-2659E251-5FC4-411B-8792-CDCCEE117885

Q42131253-799B218A-BC1A-41D2-B7B4-99315FC10A1E

Q42131253-D2D0DC8A-F9C4-4156-A60A-9533B8270A73

P2860

Q42131253-09274EC3-2D4B-49B3-AF4F-C0AF956A4D8B

Q42131253-0B2857DD-CD97-40DC-AA47-FC9720E19635

Q42131253-0C0CA617-845D-467B-89DC-7258247A9BD7

Q42131253-19CE3DB2-28A4-4C01-B012-8184AA18B914

Q42131253-22AECFE7-F944-4B0A-B516-63C6AC641205

Q42131253-2B403EB3-4C44-445A-9933-6742AC3E54F9

Q42131253-37A6DAD5-6FE2-426D-A5EC-B1D49A762B70

Q42131253-37DAEDD2-A9F8-489E-8A75-F7B168A3559E

Q42131253-3916CE32-5B62-4621-B33E-C81252AD9716

Q42131253-3EC4688E-8F1E-4009-8D30-648939A0D68B

P304

Q42131253-85E807E8-88DA-47EB-AFE6-B560AA9EDA58

P31

Q42131253-4E0F58FE-3D16-477D-98BA-03B7D60CD1B7

P356

Q42131253-D41EA2F4-61F5-43D7-BF23-72110FACCB3C

P407

Q42131253-A2251660-043E-49DB-A646-D515A9CBB0AF

P433

Q42131253-6C76FADE-0B7B-4AD8-AA5B-DB4589E8D0DF

P478

Q42131253-7BBEC8DC-3F8C-4B89-9470-2BEDF265288D

P577

Q42131253-C814338E-397A-4C29-AC1A-0C27D4EBB7C8

P5875

Q42131253-1B89AB5A-11BC-4BA2-ADD8-A8728D7CE617

P698

Q42131253-75459AC6-FE31-49C3-B9F6-DCBB4E4D4C83

P932

Q42131253-7A53D400-BCF8-4C1B-985E-0E17905AC75A

P356

P1433

Molecular Pharmaceutics

P1476

The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

@en

P2093

Arik Dahan

http://www.w3.org/2001/XMLSchema#string

Gordon L Amidon

http://www.w3.org/2001/XMLSchema#string

Hans Lennernäs

http://www.w3.org/2001/XMLSchema#string

P2860

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Membrane transporters in drug development

Animal data: the contributions of the Ussing Chamber and perfusion systems to predicting human oral drug delivery in vivo.

What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs.

Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.

Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats.

Coexistence of passive and carrier-mediated processes in drug transport.

Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy.

P304

1847-1851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP300140H

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224823394

http://www.w3.org/2001/XMLSchema#string

P698

22524707

http://www.w3.org/2001/XMLSchema#string

P932

3482341

http://www.w3.org/2001/XMLSchema#string